Hot Topics Banner

The Use of Genetics in Guiding Therapy

Click CC to turn on closed captioning.

June 2012

In recent years, the Food and Drug Administration has introduced pharmacogenetic-related drug label warnings and precautions, including black box warnings, on some widely prescribed drugs in an effort to reduce adverse effects. Advances in the study of pharmacogenomics have resulted in development of tests to identify patients who would benefit from different treatment levels or the use of different drugs. Dr. Baudhuin provides an update of pharmacogenetics with a focus on drugs with FDA label warnings and precautions, the related pharmacogenetic tests available, and their use in the clinical setting.


Related Tests

Print Options

Forward to a Colleague

Share this presentation with:

  • General Practitioners
  • Internal Medicine Physicians
  • Laboratorians

If you have questions, email .